A wealth of data from genetic, epigenetic, and postmortem data support the fact that increased FKBP5 expression is associated with the risk of mental disorders, and the manipulation of FKBP5 in preclinical studies leads to the normalization of impaired behavior [108]. This evidence concerns the gene FKBP5 and psychiatric disorder.